Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 560.00
+10.00 (1.82%)
At close: Nov 26, 2025
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 110.64 billion as of November 26, 2025. Its market cap has decreased by -32.12% in one year.
Market Cap
110.64B
Enterprise Value
326.68B
Revenue
74.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
560.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 110.64B, an increase of 3,378.65%. That is a compound annual growth rate of 12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 110.64B | -15.41% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | 524.12B | 60.07% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 39.84T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.54T |
| Yuhan | 8.60T |
| Peptron | 7.30T |
| LigaChem Biosciences | 6.25T |